🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 21 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/08/1986 | 5,75 | 5,79 | 5,73 | 5,73 | -0,12% | 1,15% | 5.583.744 |
| 06/08/1986 | 5,70 | 5,76 | 5,69 | 5,74 | +0,70% | 1,40% | 6.223.234 |
| 05/08/1986 | 5,67 | 5,74 | 5,67 | 5,70 | +0,47% | 1,17% | 5.574.312 |
| 04/08/1986 | 5,67 | 5,74 | 5,63 | 5,67 | -0,81% | 1,87% | 5.197.032 |
| 01/08/1986 | 5,66 | 5,75 | 5,63 | 5,72 | +1,29% | 1,99% | 6.108.163 |
| 31/07/1986 | 5,57 | 5,70 | 5,57 | 5,65 | +1,19% | 2,38% | 6.379.805 |
| 30/07/1986 | 5,48 | 5,62 | 5,45 | 5,58 | +1,94% | 3,02% | 6.764.630 |
| 29/07/1986 | 5,50 | 5,52 | 5,46 | 5,47 | +0,24% | 1,09% | 4.374.562 |
| 28/07/1986 | 5,51 | 5,54 | 5,41 | 5,46 | -0,84% | 2,41% | 6.059.117 |
| 25/07/1986 | 5,51 | 5,53 | 5,46 | 5,51 | -0,12% | 1,20% | 7.698.398 |
| 24/07/1986 | 5,51 | 5,53 | 5,49 | 5,51 | -0,24% | 0,72% | 4.376.448 |
| 23/07/1986 | 5,62 | 5,64 | 5,49 | 5,53 | -1,65% | 2,59% | 7.221.139 |
| 22/07/1986 | 5,38 | 5,62 | 5,38 | 5,62 | +4,95% | 4,43% | 10.633.637 |
| 21/07/1986 | 5,36 | 5,41 | 5,33 | 5,35 | -0,98% | 1,36% | 3.318.178 |
| 18/07/1986 | 5,44 | 5,50 | 5,38 | 5,41 | +0,24% | 2,19% | 13.900.882 |
| 17/07/1986 | 5,26 | 5,41 | 5,26 | 5,39 | +2,91% | 2,90% | 9.039.629 |
| 16/07/1986 | 5,25 | 5,27 | 5,22 | 5,24 | +0,13% | 1,01% | 6.076.094 |
| 15/07/1986 | 5,22 | 5,27 | 5,17 | 5,23 | +0,25% | 2,03% | 10.575.158 |
| 14/07/1986 | 5,25 | 5,29 | 5,22 | 5,22 | -1,87% | 1,26% | 4.980.096 |
| 11/07/1986 | 5,29 | 5,37 | 5,27 | 5,32 | +0,63% | 1,88% | 5.442.264 |
| 10/07/1986 | 5,28 | 5,29 | 5,20 | 5,29 | +0,12% | 1,76% | 7.177.752 |
| 09/07/1986 | 5,28 | 5,29 | 5,23 | 5,28 | +0,13% | 1,13% | 5.163.077 |
| 08/07/1986 | 5,27 | 5,29 | 5,06 | 5,27 | -1,73% | 4,27% | 6.813.677 |
| 07/07/1986 | 5,49 | 5,49 | 5,31 | 5,37 | -2,29% | 3,14% | 5.625.245 |
| 03/07/1986 | 5,58 | 5,58 | 5,46 | 5,49 | -1,66% | 2,14% | 4.217.990 |
| 02/07/1986 | 5,60 | 5,61 | 5,55 | 5,59 | -0,24% | 1,06% | 3.431.362 |
| 01/07/1986 | 5,49 | 5,60 | 5,49 | 5,60 | +1,08% | 2,05% | 4.766.933 |
| 30/06/1986 | 5,51 | 5,61 | 5,50 | 5,54 | +1,09% | 2,04% | 5.781.816 |
| 27/06/1986 | 5,43 | 5,50 | 5,41 | 5,48 | +1,22% | 1,59% | 5.008.392 |
| 26/06/1986 | 5,38 | 5,43 | 5,31 | 5,41 | +0,49% | 2,34% | 3.991.622 |